V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009851 | 270012862 | 1.8 | 25.4 | Curative (C) | 2013-11-04 | 2013-11-22 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + ETOPOSIDE | N | N | 270021257 | NOT MATCHED |
| 270009852 | 270005808 | 1.68 | 69.5 | Curative (C) | 2013-07-03 | 2013-07-04 | Capecitabine (21 day) + Irinotecan | N | N | 270021264 | CHLVPP/PABLOE |
| 270009853 | 270012863 | 1.59 | 118.7 | Curative (C) | 2016-10-19 | 2016-11-03 | Bendamustine +/- Prednisolone | N | Y | 270021271 | CHOP |
| 270009854 | 270012863 | null | 96 | null | 2013-03-14 | 2013-03-25 | ABVD R | N | N | 270021271 | CVP R |
| 270009855 | 270012863 | 1.74 | 83 | Disease modification (D) | 2017-02-13 | 2017-02-28 | null | N | N | 270021271 | CVP R |
| 270009856 | 270012863 | 1.54 | 53 | Curative (C) | null | 2015-02-18 | CVP R | null | null | 270021271 | CVP R |
| 270009857 | 270012863 | 1.7 | 102 | Curative (C) | 2016-05-26 | 2016-06-25 | Chlorambucil | N | Y | 270021271 | VINBLASTINE |
| 270009858 | 270012863 | 1.75 | 70 | null | 2013-06-17 | 2013-06-18 | Rituximab | 2 | N | 270021271 | RITUXIMAB |
| 270009859 | 270005809 | null | null | Curative (C) | 2017-01-30 | 2017-01-30 | Rituximab | null | N | 270021304 | NOT MATCHED |
| 270009860 | 270005809 | 1.6 | 54.5 | Palliative (P) | 2015-08-17 | 2015-08-17 | CHOP - 21 days | N | N | 270021304 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009861 | 270005810 | 1.68 | 62.7 | Curative (C) | 2016-10-11 | 2016-10-21 | IBRUTINIB | N | null | 270021329 | CVP R |
| 270009862 | 270005810 | 1.88 | 66.4 | null | 2013-08-16 | 2013-08-26 | Brentuximab | 02 | null | 270021329 | AXITINIB |
| 270009863 | 270005811 | 1.8 | 90.2 | Palliative (P) | 2017-09-19 | 2017-09-27 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270021342 | GEMCITABINE + OXALIPLATIN |
| 270009864 | 270005812 | null | 55 | null | 2015-05-15 | 2015-05-15 | R GCVP | N | N | 270021351 | CVP R |
| 270009865 | 270005813 | 1.75 | 108 | Curative (C) | 2014-09-13 | 2014-09-24 | Vincristine (weekly) | N | N | 270021355 | RITUXIMAB |
| 270009866 | 270005814 | 1.59 | 56 | Curative (C) | 2013-09-23 | 2013-10-08 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 01 | N | 270021359 | IVE |
| 270009867 | 270012866 | 1.62 | 51 | Disease modification (D) | 2013-06-21 | 2013-06-27 | null | 2 | N | 270021362 | CHLORAMBUCIL |
| 270009868 | 270005815 | 1.62 | null | Curative (C) | 2017-02-15 | 2017-02-23 | Rituximab | 02 | N | 270021365 | ESHAP |
| 270009869 | 270005816 | 1.88 | 95 | Palliative (P) | 2013-11-27 | 2013-11-27 | null | 02 | N | 270021369 | BEAM + ALEMTUZUMAB |
| 270009870 | 270005816 | 1.65 | null | Palliative (P) | 2017-09-27 | 2017-09-27 | null | N | null | 270021369 | IRINOTECAN |
| 270009871 | 270005817 | 1.69 | 106 | Curative (C) | 2013-02-18 | 2013-02-27 | CHOP - 21 days | N | N | 270021372 | CVP R |
| 270009872 | 270005817 | 1.74 | 83.8 | Curative (C) | 2013-05-23 | 2013-05-26 | LOPP | 02 | N | 270021372 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270009873 | 270005817 | 1.7 | 67 | Curative (C) | 2014-08-08 | 2014-08-19 | DHAP | 02 | N | 270021372 | NOT MATCHED |
| 270009874 | 270005817 | 1.63 | 74.4 | Curative (C) | 2015-02-03 | 2015-03-05 | Docetaxel | N | N | 270021372 | ABVD R |
| 270009875 | 270005817 | 1.6 | null | Curative (C) | null | 2017-09-22 | BREVITY TRIAL | null | null | 270021372 | IBRUTINIB |
| 270009876 | 270005817 | 1.6 | 52.4 | Curative (C) | 2018-01-28 | 2018-02-01 | ECHELON-2 TRIAL | N | N | 270021372 | IMATINIB |
| 270009877 | 270005817 | 1.77 | 54 | null | 2014-10-16 | 2014-10-23 | Carboplatin + Etoposide iv&po | 99 | null | 270021372 | CHLORAMBUCIL |
| 270009878 | 270005818 | 1.68 | 76 | Adjuvant (A) | 2017-07-06 | 2017-07-09 | R ABVD | N | N | 270021458 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270009879 | 270005819 | 1.61 | 51.9 | Palliative (P) | 2017-06-17 | 2017-06-21 | CYCLOPHOSPHAMIDE + VINBLASTINE | 02 | N | 270021460 | CVP R |
| 270009880 | 270005819 | null | null | null | null | 2016-03-16 | Bevacizumab + Capecitabine | null | null | 270021460 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009881 | 270016052 | null | null | Curative (C) | 2017-06-14 | 2017-06-14 | COPP + Dacarbazine | N | null | 270021477 | CARBOPLATIN + PEMETREXED |
| 270009882 | 270016052 | 1.63 | 51.1 | Curative (C) | 2017-08-29 | 2017-08-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270021477 | CYCLOPHOSPHAMIDE |
| 270009883 | 270005820 | null | null | Palliative (P) | null | 2013-12-19 | DOXORUBICIN | null | null | 270021485 | CVP R |
| 270009884 | 270012870 | 1.68 | null | Curative (C) | null | 2015-02-26 | CHOP - 21 days | null | null | 270021486 | IVE |
| 270009885 | 270005821 | null | 46 | Curative (C) | 2016-04-20 | 2017-04-23 | R GCVP | null | null | 270021504 | COPP + DACARBAZINE |
| 270009886 | 270005821 | 1.73 | 83 | Curative (C) | 2018-08-01 | 2018-08-04 | GEMCITABINE | N | N | 270021504 | VEDEX |
| 270009887 | 270005822 | 1.75 | 64 | Palliative (P) | 2016-12-17 | 2016-12-24 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 2 | N | 270021520 | BENDAMUSTINE + RITUXIMAB |
| 270009888 | 270005823 | 1.73 | 57.5 | Curative (C) | 2016-02-14 | 2016-02-14 | CVP | N | N | 270021522 | BENDAMUSTINE + RITUXIMAB |
| 270009889 | 270005824 | 1.67 | 54 | Curative (C) | 2014-07-22 | 2014-07-24 | CISPLATIN + ETOPOSIDE | Y | N | 270021523 | ABVD R |
| 270009890 | 270005825 | 1.73 | 71.2 | Disease modification (D) | 2017-01-17 | 2017-01-27 | GDP | N | N | 270021527 | CVP R |
| 270009891 | 270005826 | 1.58 | 28.1 | Palliative (P) | 2017-08-17 | 2017-09-12 | CVP R | 2 | Y | 270021549 | ABVD R |
| 270009892 | 270005827 | null | 87.5 | Curative (C) | null | 2014-11-30 | Escalated BEACOP Dac | null | null | 270021553 | CVP R |
| 270009893 | 270005827 | 1.73 | 59.6 | Disease modification (D) | null | 2013-09-11 | CVP R | N | N | 270021553 | CVP |
| 270009894 | 270005827 | 1.55 | 40 | Curative (C) | 2017-11-07 | 2017-12-03 | CVP R | N | N | 270021553 | LOPP |
| 270009895 | 270005827 | 1.74 | 72.7 | Curative (C) | null | 2013-06-10 | CVP R | N | N | 270021553 | RITUXIMAB |
| 270009896 | 270005827 | 1.6 | null | Curative (C) | 2017-01-01 | 2017-01-06 | CVP R | N | N | 270021553 | CHOP |
| 270009897 | 270005828 | 1.67 | 57.1 | Curative (C) | 2015-04-14 | 2015-04-30 | BREVITY TRIAL | N | N | 270021595 | ICE |
| 270009898 | 270012873 | 1.6 | 0 | Adjuvant (A) | 2017-07-13 | 2017-08-06 | Rituximab (Maintenance) | N | N | 270021597 | NOT MATCHED |
| 270009899 | 270012873 | 1.63 | 57 | Disease modification (D) | 2016-05-09 | 2016-05-15 | HD EuroNet-PHL | N | N | 270021597 | GDCVP |
| 270009900 | 270017863 | 1.69 | 74.9 | Palliative (P) | 2015-08-12 | 2015-08-18 | Mitomycin Intravesical | 02 | Y | 270021603 | CVP R |